Jesús Frías

Mount Sinai Hospital — United States

Medicine · Health Sciences

26h-index2.8kcitations142works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(18), Pharmacogenetics and Drug Metabolism(15), Antibiotics Pharmacokinetics and Efficacy(13), Pharmaceutical studies and practices(13), COVID-19 Clinical Research Studies(11)

Publications141 total

MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility
Proceedings of the National Academy of Sciences·2025Open Access
Association of Time-To-Anticoagulation (TTAC) With Right Ventricular(RV) Function on Outpatient Follow-up Among Patients With Acute Pulmonary Embolism (PE) Managed by the Pulmonary Embolism Response Team (PERT): A Retrospective Study
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Causes of Re-admissions Among Patients With Acute Pulmonary Embolism: A Retrospective Analysis
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Pulmonary Arterial Pulsatility Index in Portopulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine·2025
Immunogenicity, Reactogenicity and Safety to Assess Booster Vaccinations with BNT162b2 or Full-Dose mRNA-1273 in Adults ≥75 Years (EU-COVAT-1-AGED) – Final Report
SSRN Electronic Journal·2025Open Access
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1
Molecular Therapy — Nucleic Acids·2024· 9 citedOpen Access
Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1
Human Molecular Genetics·2024· 2 citedOpen Access
CAG repeat-selective compounds reduce abundance of expanded CAG RNAs in patient cell and murine models of SCAs
2024· 2 citedOpen Access
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants
iScience·2024Open Access
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
International Journal of Infectious Diseases·2024· 1 citedOpen Access
Corrigendum to: An account on the history of pharmacology in Spain [Pharmacol. Res. 202 (2024) 107104 Pages 1–11 https://doi.org/10.1016/j.phrs.2024.107104]
Pharmacological Research·2024Open Access
Identifying Novel Therapeutics And Modifiers Of Myotonic Dystrophy Type 1
2024Open Access
An account on the history of pharmacology in Spain
Pharmacological Research·2024Open Access
Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial—POSCAL Study
Nutrients·2024· 3 citedOpen Access
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium
Vaccines·2023· 3 citedOpen Access
2383. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised trial in adults ≥75 years (EU-COVAT-1) from the VACCELERATE consortium
Open Forum Infectious Diseases·2023· 1 citedOpen Access
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)
Vaccine·2023· 9 citedOpen Access
Bioavailability of Cariban® Capsules: A Modified-Release Fixed-Dose Combination of Doxylamine and Pyridoxine to Relieve Nausea and Vomiting During Pregnancy
Drugs in R&D·2023· 3 citedOpen Access
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe
Vaccine·2023· 11 citedOpen Access
Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit
JMIR Public Health and Surveillance·2023· 5 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Antonio J. Carcas(34), Alberto M. Borobia(28), Elena Ramı́rez(27), Hoi Y. Tong(12), Francisco Abad‐Santos(7), Pedro Ignacio Cardona Guerra(6), José Ramón Arribas(5), Jordi Ochando(5), Julio García‐Rodríguez(5), Nicolás Medrano(5), Irene García-García(4), Enrique Piñana(4), Mario Muñoz(4), Carlos Govantes(4), María González-Pérez(3), Cristóbal Belda-Iniesta(3), Jaime Monserrat Villatoro(3), Antonio Buño Soto(3), Esther Rey Cuevas(3), Manuel Quintana(3)